Literature DB >> 4829619

Acetylcholine and depression.

D S Janowsky, M K el-Yousef, J M Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4829619     DOI： 10.1097/00006842-197405000-00008

Source DB:  PubMed          Journal:  Psychosom Med        ISSN： 0033-3174            Impact factor:   4.312


× No keyword cloud information.
  56 in total

Review 1.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

Review 2.  Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.

Authors:  Paul R Sanberg; Cecilia Vindrola-Padros; R Douglas Shytle
Journal:  Physiol Behav       Date:  2012-07-06

Review 3.  Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

Authors:  Maura L Furey; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

Review 4.  Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.

Authors:  Jun Chen; Yiru Fang; David E Kemp; Joseph R Calabrese; Keming Gao
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

5.  Oxotremorine treatment restores hippocampal neurogenesis and ameliorates depression-like behaviour in chronically stressed rats.

Authors:  J Veena; B N Srikumar; K Mahati; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

6.  Scopolamine as an antidepressant agent: theoretical and treatment considerations.

Authors:  David S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 5.285

7.  Psychiatry-epitomes of progress: cholinergic hypersensitivity in patients with affective disorders.

Authors:  D S Janowsky
Journal:  West J Med       Date:  1981-02

8.  Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression.

Authors:  Sabrina Bassi; Marianne L Seney; Pablo Argibay; Etienne Sibille
Journal:  J Psychiatr Res       Date:  2015-02-20       Impact factor: 4.791

9.  The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.

Authors:  Maura L Furey
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

10.  Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Authors:  D M Cannon; J K Klaver; S K Gandhi; G Solorio; S A Peck; K Erickson; N Akula; J Savitz; W C Eckelman; M L Furey; B J Sahakian; F J McMahon; W C Drevets
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.